The Effect of Caffeine Therapy in Cardiovascular Stability in Preterm Neonates at Assiut University Children Hospital NICU

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeUp to 37

SponsorAssiut University

About this trial

Preterm neonates younger than 37 weeks gestational age receiving caffeine therapy for apnea of prematurity in a NICU setting.

Preterm neonates with gestational age <37 weeks

Receiving caffeine therapy for apnea of prematurity

Hemodynamically stable before caffeine initiation

Presence of major congenital anomalies

Use of vasopressors at baseline

Severe intraventricular hemorrhage (Grade III-IV)

40 Participants

are grouped into 1 trial group

This trial has no locations

Assiut University

Lead sponsor